These studies suggest that the gut microbiome may upregulate inflammatory pathways in IBD through the binding of gut bacterial peptides to host signaling proteins that modulate TF activity12 or through Toll-like receptor activation that triggers upstream signaling cascades.13 This evidence concerns the gene TF and inflammatory bowel disease.